Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Xylometazoline 0.1% nasal spray
1202020P0AAACAC
|
Xylometazoline hydrochloride | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | 5,125 |
|
Xylometazoline 0.1% nasal drops
1202020P0AAABAB
|
Xylometazoline hydrochloride | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | 1,229 |
|
Xylometazoline 0.05% nasal drops
1202020P0AAAAAA
|
Xylometazoline hydrochloride | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | 904 |
|
Otrivine Adult nasal spray
1202020P0BBAAAC
|
Otrivine | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | 769 |
|
Sudafed Blocked Nose 0.1% spray
1202020P0BJAAAC
|
Sudafed (Nasal) | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | 311 |
|
Otrivine Adult 0.1% nasal drops
1202020P0BBADAB
|
Otrivine | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | 287 |
|
Otrivine Child nasal drops
1202020P0BBACAA
|
Otrivine | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | 224 |
|
Otrivine Adult Metered Dose 0.1% nasal spray
1202020P0BBAIAC
|
Otrivine | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | 130 |
|
Otrivine Congestion Relief 0.1% nasal spray
1202020P0BBAKAC
|
Otrivine | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | 44 |
|
Otrivine Adult Measured Dose Sinusitis spray
1202020P0BBAHAC
|
Otrivine | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | 38 |
|
Otrivine Allergy Relief 0.1% nasal spray
1202020P0BBAJAC
|
Otrivine | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | 17 |
|
Sudafed Congestion Relief 0.1% nasal spray
1202020P0BJACAC
|
Sudafed (Nasal) | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | 8 |
|
Sudafed Sinus-Ease 0.1% nasal spray
1202020P0BJAEAC
|
Sudafed (Nasal) | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | 3 |
|
Sudafed Mucus Relief 0.1% nasal spray
1202020P0BJABAC
|
Sudafed (Nasal) | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | 1 |
|
Otradrops Adult Formula 0.1% nasal drops
1202020P0BGABAB
|
Otradrops | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | No data available |
|
Otradrops Child nasal drops
1202020P0BGAAAA
|
Otradrops | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | No data available |
|
Otraspray nasal spray
1202020P0BHAAAC
|
Otraspray | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | No data available |
|
Otrivine Adult Menthol nasal spray
1202020P0BBAGAC
|
Otrivine | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | No data available |
|
Tixycolds Cold and Allergy nasal drops
1202020P0BIAAAA
|
Tixycolds (Nasal) | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.